TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05158036

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Classic massage group
Description: Classic massage application will be given to the Classic massage group

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Connective tissue masage
Description: Connective tissue masage application will be given to the Connective tissue masage group
Study: NCT05261295

Intervention type: DIAGNOSTIC_TEST
Intervention: PEEP
Description: PEEP of 7 cmH2O will be applied 5 minutes after classical LMA or i-gel insertion.

Intervention type: DIAGNOSTIC_TEST
Intervention: PEEP
Description: PEEP of 7 cmH2O will be applied 5 minutes after classical LMA or i-gel insertion.
Study: NCT06106178

Intervention type: OTHER
Group type: OTHER
Intervention: Serious Video Game
Description: The serious video game Underwater uses a 3D-printed ultrasound probe for maneuvering. During gameplay, coins must be collected in an underwater world using the aforementioned simulated ultrasound probe. The main focus of this game is to improve hand-eye coordination while using an ultrasound probe.
Study: NCT05557981

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Coaching
Description: A novel coaching curriculum based in positive psychology with an emphasis on self-reflection, goal setting and adverse event processing.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Coaching
Description: A novel coaching curriculum based in positive psychology with an emphasis on self-reflection, goal setting and adverse event processing.
Study: NCT05261295

Intervention type: DIAGNOSTIC_TEST
Intervention: ZEEP
Description: PEEP of 0 cmH2O will be applied 5 minutes after classical LMA or i-gel insertion.

Intervention type: DIAGNOSTIC_TEST
Intervention: ZEEP
Description: PEEP of 0 cmH2O will be applied 5 minutes after classical LMA or i-gel insertion.
Study: NCT05124262

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Low- FODMAPdiet group intervention
Description: Diet intervention

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Low- FODMAPdiet group intervention
Description: Diet intervention
Study: NCT05076240

Intervention type: PROCEDURE
Intervention: FilmArray® analysis
Description: FilmArray® multiplex PCR analysis to diagnose ventilator associated pneumonia in COVID-19 ARDS
Study: NCT06081257

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: KB-120 small molecular nutrient and vitamin E
Description: The experimental group was given oral KB-120 small molecular nutrients, once a day, once a bag (30ml), and vitamin E100mg orally twice a day for a total of 3 menstrual cycles

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Vitamin E
Description: Vitamin E100mg is taken orally twice a day for a total of 3 menstrual cycles
Study: NCT05354973

Intervention type: DEVICE
Intervention: Consilium CareTM
Description: This is an observational study using the Consilium CareTM smartphone ePRO application.
Study: NCT06081257

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Vitamin E
Description: Vitamin E100mg is taken orally twice a day for a total of 3 menstrual cycles
Study: NCT06293404

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bupivacain
Description: 7.5 mg Bupivacaine hydrochloride (0.5% heavy Marcaine) will be used on spinal anesthesia. (each group)
Study: NCT05409092

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Astaxanthin
Description: 8 mg/day in one capsule for 4 weeks

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 8 mg/day in one capsule for 4 weeks
Study: NCT06402617

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Pulmonary vein isolation
Description: Standard clinical radio-frequency ablation isolation of pulmonary veins

Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Pulmonary vein isolation
Description: Standard clinical radio-frequency ablation isolation of pulmonary veins

Intervention type: DIAGNOSTIC_TEST
Group type: PLACEBO_COMPARATOR
Intervention: RETRO-Mapping without adjunctive ablation
Description: RETRO-Mapping performed using research equipment and software, but without any adjunctive ablation

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Adjunctive ablation guided by RETRO-Mapping
Description: Radio-frequency ablation using a European conformity (CE)-marked ablation catheter of sites of focal activation identified by RETRO-Mapping
Study: NCT05363514

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Low Dose Naltrexone
Description: Participant takes Low Dose Naltrexone 4.5mg PO OD for 120 days. Participant will complete a a 4 week titration to target dose of 4.5mg. Week 1-2: 1.5mg PO OD. Week 3-4: 3.0mg PO OD. Week 5-16: 4.5mg PO OD. Participant will be provided with masked capsules in blister packs.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Microcrystalline cellulose
Description: Participant takes microcrystalline cellulose 4.5mg PO OD for 120 days. Participant will complete a a 4 week titration to target dose of 4.5mg. Week 1-2: 1.5mg PO OD. Week 3-4: 3.0mg PO OD. Week 5-16: 4.5mg PO OD. Participant will be provided with masked capsules in blister packs.
Study: NCT05490485

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Camrelizumab
Description: Camrelizumab combined with cisplatin for advanced cutaneous squamous cell carcinoma
Study: NCT05220943

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Video
Description: This 5-minute video presents clips with voiceover narration summarizing and highlighting the key safety points in the Center for Surgical Innovation (CSI) location.
Study: NCT05498675

Intervention type: DRUG
Intervention: Sacubitril / Valsartan Oral Tablet [Entresto]
Description: There is no treatment allocation. Patients administered sacubitril / valsartan oral tablet (Entresto) 200mg 1/day by prescription that have started before inclusion of the patient enrolled into the study and defined as sacubitril/valsartan group.

Intervention type: DRUG
Intervention: ACEI/ARB
Description: There is no treatment allocation. Patients administered angiotensin-converting enzyme inhibitors/angiotensin II receptor antagonists (ACEI/ARB) by prescription that have started before inclusion of the patient enrolled into the study and defined as ACEI/ARB group.~Including:~benazepril, captopril, enalapril, fosinopril, lisinopril, moexipril, perindopril, quinapril, ramipril, trandolapril, azilsartan, candesartan, eprosartan, irbesartan, losartan, olmesartan, telmisartan, valsartan.
Study: NCT05569551

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Adhesive pouch
Description: Is a barrier dressing categorized under class C medical device. It is used to seal up the umbilical stump to prevent contamination until its cord detachment. It has an adhesive film that sticks to skin with a centrally located non-adhesive pouch ensuring that zero pressure is applied on the umbilicus. It is made of polyurethane, the same material as transparent intravenous cannula dressings making it hypoallergenic waterproof and breathable.
Study: NCT04475783

Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: Percutaneous Transluminal Angioplasty (PTA)
Description: PTA with an drug-coated balloon catheter (DCB) in the femoropopliteal artery

Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Percutaneous Transluminal Angioplasty (PTA)
Description: PTA with an drug-coated balloon catheter (DCB) in the femoropopliteal artery
Study: NCT05262998

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Plate fixation
Description: Procedure: plate fixation~Plate fixation was performed by the regular on-call team surgeons and adhered to standard principles of fracture fixation. A standard surgical protocol was used, the approach was moved inferiorly, the fracture was reduced, sometimes with osteosutur and fixed with an antero-superior anatomical plate. 3.5mm Locked and cortical screws were used on both sides of the fracture. Fluoroscopy was used during the procedure. Intradermal suture was used to close the skin~Other: post-intervention All patients were discharged the day after the surgery. Interruption of work was given for 45 days. The same analgesics were administered in both groups for three weeks. Graduated exercises for the shoulder joint with pendular movements in a range of 15°-20° with the protection of a forearm sling were commenced from the postoperative second day. The sling was removed when X-ray films showed growth of callus or an indistinct fracture line.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Intramedullary Screw
Description: Procedure: Intramedullary screw fixation~Intramedullary screw fixation was performed by the regular on-call team surgeons and adhered to standard principles of fracture fixation. Intramedullary screw fixation was performed by using a 1.6 or 2.8 mm-diameter threaded guide pin and a 85-100 mm long, 4.5 or 6.5 mm-diameter cannulated screw tapped in along the guide pin. Fluoroscopy was used during the procedure. Intradermal suture was used to close the skin.~Other: post-intervention All patients were discharged the day after the surgery. Interruption of work was given for 45 days. The same analgesics were administered in both groups for three weeks. Graduated exercises for the shoulder joint with pendular movements in a range of 15°-20° with the protection of a forearm sling were commenced from the postoperative second day. The sling was removed when X-ray films showed growth of callus or an indistinct fracture line.
Study: NCT05631223

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Telemedicine
Description: The intervention will consist of two structured telemedicine visits delivered between two routine office visits and conducted by providers (nurse practitioners and clinical nurse specialists).
Study: NCT06232330

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Group A
Description: This group will receive TOA which include Weight transfers from a standing position and stepping in various star-type directions, Sit-ups from different heights with the hemiplegic lower limb behind the normal lower limb, From a kneeling position alternately projecting the lower limb forward, From a standing position with a limited base of support turning head and trunk right to left, Continuous walking on a treadmill for 10 minutes, Ascending and descending of stairs, Crossing 4 obstacles with continuous walking, Walking while simultaneously pushing a stroller, Walking while holding an object, Walking on different surfaces and slopes, The intervention took place for 5 days a week for 6 week for 20 minutes. Pre measurement was taken before the intervention and after 6 weeks post measurement was taken.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Group B
Description: This group will receive PNF techniques for trunk control. Rhythmic initiation and Rhythmic stabilization for a span of 20 minutes on both sides. In rhythmic initiation patient will move passively from trunk flexion into extension and then back to the flexed position When the patient is relaxed and moving easily, ask for active assisted motion Then begin resisting the motion then patient will perform independently in rhythmic stabilization Resist an isometric contraction of the patient's trunk flexor muscles patient will match the resistance in front and then in back
Study: NCT04470687

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: contrast enhanced ultrafast ultrasound imaging
Description: Ultrasound contrast medium: SonoVue 8µL/mL (Bracco International BV) Ultrasound scanner: Aixplorer® device marketed by SuperSonic Imagine©, CE Doppler UltraFast™Doppler, contrast ultrasound (CEUS), color Doppler and ultra-sensitive energy Doppler, high-performance directional energy Doppler, Elastography ShearWave™ UF-Doppler (UltraFast-Doppler) and microbubble injection (SonoVue) Apparatus for performing the UF Doppler sequence: Aixplorer, manufacturer : Supersonic Imagine, Aix-en-Provence, France, CE Marking.~3D RCA dedicated vascular probe with dedicated Doppler sequences
Study: NCT05346536

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Detection of circulating tumor cells expressing Axl: CTC-AXL(+)
Description: Detection of CTC-AXL(+) using 2 techniques:~* CellSearch®, FDA-USA approved technology~* EPIDROP System~CellSearch® (Menarini Company) The current gold-standard CellSearch® technique requires the use of CellSave tubes. This technique allows the isolation of fixed CTCs. This technique uses a positive (CellSearch® Epithelial Cell Kit) enrichment method from total blood using magnetic beads coupled to an EpCAM capture antibody. CTCs are then detected (anti-panCK antibodies, DAPI, anti-CD45 and characterized (anti-AXL antibody) by immunofluorescence (IF).~EPIDROP It requires the use of EDTA tubes. This technique is based on a method of negative enrichment of CTCs from total blood using a cocktail of tetrameric antibodies to eliminate unwanted blood cells and to preserve only purified tumor cells (RosetteSep - StemCell Technology).Then, cells are loaded in a microfluidic chip. The detection and characterization is done by IF to the single cell in micro-droplets.
Study: NCT04892225

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Technology-supported behavioral intervention (text message)
Description: A simple text message regarding the salt and fluid restriction in order to reduce the inter-dialytic weight gain will be send on daily basis to all the individuals in the intervention group.
Study: NCT05326230

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Paradise™ (PRDS-001) Renal Denervation Ultrasound System
Description: Following renal angiogram according to standard procedures, subjects remain blinded and are randomized to treatment with renal denervation or sham control

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Renal Angiogram
Description: Following renal angiogram according to standard procedures, subjects remain blinded and renal angiogram is considered the sham procedure
Study: NCT04898855

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy for Insomnia
Description: Treatment includes sleep hygiene, sleep restriction, stimulus control, and cognitive therapy.
Study: NCT05656001

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Real-time functional magnetic resonance imaging Neurofeedback and Real-time Biofeedback
Description: Participants will take part in three runs of real-time functional magnetic resonance imaging feedback (rt-fMRI-NF) training with 4-8 days apart, which will be conducted at the Center for Medical Image Science and Visualization (CMIV) at the university hospital in Linköping. Participants who receive biofeedback will take part in three runs of biofeedback with 4-8 days apart conducted in the lab at the Center for Social and Affective Neuroscience (CSAN) at Linköping university. Participants will be given instructions and basic psychoeducation of brain function and the rational for down-regulating the area of the brain that drives emotion, as well as the physiological reaction that is triggered in response to emotional stimuli. The emotional stimuli are emotional pictures from the International Affective Picture System (IAPS) and the Open Affective Standardized Image Set (OASIS).

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham functional magnetic resonance imaging neurofeedback and sham biofeedback
Description: Participants will take part in three runs of sham neurofeedback with 4-8 days apart, which will be conducted at the Center for Medical Image Science and Visualization (CMIV) at the university hospital in Linköping. Participants who receive sham biofeedback will take part in three runs of sham biofeedback with 4-8 days apart conducted in the lab at the Center for Social and Affective Neuroscience (CSAN) at Linköping university. Participants will be given instructions and basic psychoeducation of brain function and the rational for down-regulating the area of the brain that drives emotion, as well as the physiological reaction that is triggered in response to emotional stimuli. The emotional stimuli are emotional pictures from the International Affective Picture System (IAPS) and the Open Affective Standardized Image Set (OASIS).
Study: NCT05984875

Intervention type: OTHER
Intervention: Collection of tumor samples, blood and vaginal and rectal swabs
Description: The following biological samples will be collected at different time points, according to the specified cohort and after signing the inform consent form: tumor tissue (fresh and archival) or normal tissue (cohort E), ascites (when present), peripheral blood, rectal swab, vaginal swab.

Intervention type: OTHER
Intervention: Collection of tumor samples, blood and vaginal and rectal swabs
Description: The following biological samples will be collected at different time points, according to the specified cohort and after signing the inform consent form: tumor tissue (fresh and archival) or normal tissue (cohort E), ascites (when present), peripheral blood, rectal swab, vaginal swab.

Intervention type: OTHER
Intervention: Collection of tumor samples, blood and vaginal and rectal swabs
Description: The following biological samples will be collected at different time points, according to the specified cohort and after signing the inform consent form: tumor tissue (fresh and archival) or normal tissue (cohort E), ascites (when present), peripheral blood, rectal swab, vaginal swab.

Intervention type: OTHER
Intervention: Collection of tumor samples, blood and vaginal and rectal swabs
Description: The following biological samples will be collected at different time points, according to the specified cohort and after signing the inform consent form: tumor tissue (fresh and archival) or normal tissue (cohort E), ascites (when present), peripheral blood, rectal swab, vaginal swab.
Study: NCT05782959

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: BCD-245
Description: BCD-245 is administered as prolonged intravenous infusions during each cycle
Study: NCT05765214

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Intervention Group (IG)
Description: In general, the education will cover:~(i) Colorectal cancer - knowledge, perceptions, self-care, and social norms (CRC-KPSS): Knowledge; Perceptions (perceived susceptibility, perceived severity, perceived benefits, perceived barriers); Self-care; and Social norms; and information on colorectal cancer screening (ii) Healthy nutrition colorectal for cancer risk reduction and complementary to diabetes guideline (increasing consumption of fiber, fruits, vegetables, whole grains, and calcium; reducing red and processed meat, fat, added sugars and alcohol)
Study: NCT06293404

Intervention type: DRUG
Group type: OTHER
Intervention: Bupivacain
Description: 7.5 mg Bupivacaine hydrochloride (0.5% heavy Marcaine) will be used on spinal anesthesia. (each group)
Study: NCT04773860

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Muscle Energy Techniques
Description: A 4 week intervention will be carried out consisting of Muscle Energy Techniques on the accessory muscle of respiration. That is, Pectoralis Minor, Sternocleidomastoid, Upper trapezius, Scalene muscles and Latissimus Dorsi
Study: NCT06037395

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CT-P41
Description: a single 60 mg subcutaneous (SC) injection via pre-filled syringe (PFS)

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: US-licensed Prolia
Description: a single 60 mg subcutaneous (SC) injection via pre-filled syringe (PFS)
Study: NCT06278467

Intervention type: DIAGNOSTIC_TEST
Intervention: visual pain scale (VASpain/fatigue), Beck depression index (BDI),
Description: VAS (0-10)

Intervention type: DIAGNOSTIC_TEST
Intervention: visual pain scale (VASpain/fatigue), Beck depression index (BDI),
Description: VAS (0-10)

Intervention type: DIAGNOSTIC_TEST
Intervention: Pain catastrophizing scale, sleep quality with a single Likert type question in the Pittsburgh questionnaire
Description: PCS (Pain catastrophizing scale); sleep quality with a single Likert type question in the Pittsburgh questionnaire (0-3)

Intervention type: DIAGNOSTIC_TEST
Intervention: Pain catastrophizing scale, sleep quality with a single Likert type question in the Pittsburgh questionnaire
Description: PCS (Pain catastrophizing scale); sleep quality with a single Likert type question in the Pittsburgh questionnaire (0-3)

Intervention type: DIAGNOSTIC_TEST
Intervention: Roland Morris Disability Questionnaire, quality of life with Short Form-36 ( SF-36),
Description: functional disability level with Roland Morris Disability Questionnaire, quality of life with Short Form-36 ( SF-36)

Intervention type: DIAGNOSTIC_TEST
Intervention: Roland Morris Disability Questionnaire, quality of life with Short Form-36 ( SF-36),
Description: functional disability level with Roland Morris Disability Questionnaire, quality of life with Short Form-36 ( SF-36)

Intervention type: DIAGNOSTIC_TEST
Intervention: Montreal Cognitive Assessment Scale (MOCA); Standard Mini mental test (SMMT)
Description: cognitive status was measured by Montreal Cognitive Assessment Scale (MOCA) and Standard Mini mental test (SMMT)

Intervention type: DIAGNOSTIC_TEST
Intervention: Montreal Cognitive Assessment Scale (MOCA); Standard Mini mental test (SMMT)
Description: cognitive status was measured by Montreal Cognitive Assessment Scale (MOCA) and Standard Mini mental test (SMMT)
Study: NCT04755127

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Arthroscopic synovectomy of the wrist
Description: Wrist arthroscopy in day surgery setting with debulking of synovitis, inspection of cartilage, ligament, tendon and bone damage, collection of synovial biopsies and deposition of intra-articular corticosteroids (40mg triamcinolone acetonide)

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Intra-articular corticosteroid injection
Description: Injection with 40mg triamcinolone acetonide (kenacort) in the wrist
Study: NCT05263401

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: 3-hydroxybutyrate
Description: Orally administered pre-meal drinks.

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: 3-hydroxybutyrate
Description: Orally administered pre-meal drinks.
Study: NCT05911516

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Pennisetum purpureum
Description: 300mg Participants received 900mg of Pennisetum purpureum orally daily for 12 weeks
Study: NCT05986253

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Seaweed protein
Description: Novel protein extracted from seaweed

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Maltodextrin
Description: maltodextrin solution

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Maltodextrin
Description: maltodextrin solution
Study: NCT05779423

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ipilimumab
Description: Monoclonal antibody administered through intravenous infusion

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nivolumab
Description: Monoclonal antibody administered through intravenous infusion

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Cryoablation
Description: Procedure of freezing a tumor performed via CT-guidance by interventional radiologist.
Study: NCT05263401

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: 3-hydroxybutyrate
Description: Orally administered pre-meal drinks.